Teladoc Health Inc (NYSE:TDOC) price on Thursday, May 01, fall -2.78% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.99.
A look at the stock’s price movement, the close in the last trading session was $7.19, moving within a range at $6.61 and $7.52. Turning to its 52-week performance, $15.21 and $6.35 were the 52-week high and 52-week low respectively. Overall, TDOC moved -9.92% over the past month.
Teladoc Health Inc’s market cap currently stands at around $1.23 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-29.
Analysts have a consensus estimate of 623.66M for the company’s revenue for the quarter, with a low and high estimate of 605.75M and 631.25M respectively. The average forecast suggests down to a -2.92% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.52B, representing a -2.05% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TDOC is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
19 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 9 recommend TDOC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TDOC’s current price about -2.44% and -16.55% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.61, while 7-day volatility ratio is 6.21% and 6.72% in the 30-day chart. Further, Teladoc Health Inc (TDOC) has a beta value of 1.83, and an average true range (ATR) of 0.48. Analysts have given the company’s stock an average 52-week price target of $13, forecast between a low of $13 and high of $13. Looking at the price targets, the low is -85.98% off current price level while to achieve the yearly target high, price needs to move -85.98%. Nonetheless, investors will most likely welcome a -85.98% jump to $13 which is the analysts’ median price.
If we refocus on Teladoc Health Inc (NYSE:TDOC), historical trading data shows that trading volumes averaged 5.96 over the past 10 days and 8.03 million over the past 3 months. The company’s latest data on shares outstanding shows there are 175.28 million shares.
The 1.04% of Teladoc Health Inc’s shares are in the hands of company insiders while institutional holders own 73.05% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 20.23 million on 2025-04-15, giving us a short ratio of 3.65. The data shows that as of 2025-04-15 short interest in Teladoc Health Inc (TDOC) stood at 1292.0000000000002 of shares outstanding, with shares short falling to 26.82 million registered in 2025-03-14. Current price change has pushed the stock -23.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TDOC stock continues to rise going into the next quarter.
